colorectal cancer – mycolab.ai

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune Balance

mycolabadmin

This comprehensive review explains how prebiotics—special dietary fibers that feed beneficial gut bacteria—help maintain a healthy digestive system and strong immune response. By nourishing good bacteria and directly strengthening the intestinal barrier, prebiotics can reduce harmful inflammation and potentially lower cancer risk. Different types of prebiotics like inulin and resistant starch work through both bacterial fermentation and direct immune cell interaction, making them promising tools for preventing various diseases.

Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways

mycolabadmin

Scientists studied how special medicinal mushroom extracts can fight advanced colon cancer in mice. They found that a blend called Agarikon Plus, especially when combined with a common chemotherapy drug, significantly improved survival rates and slowed tumor growth. By analyzing all the proteins in tumor tissues, they discovered the mushroom extracts work by disrupting the cancer cells’ ability to make proteins they need to survive and grow. This research suggests mushroom-based treatments could become important new weapons in the fight against advanced colorectal cancer.

Lentinan inhibits colorectal cancer stemness by binding CD133 and suppressing the CD133/p85/p-AKT signaling axis

mycolabadmin

Researchers discovered that lentinan, a natural compound from shiitake mushrooms, can specifically target and kill cancer stem cells in colorectal cancer by binding to a protein called CD133. This is significant because cancer stem cells are the reason why cancers come back even after treatment. By blocking a specific pathway these cells use to survive, lentinan may help prevent cancer recurrence and reduce the side effects associated with traditional chemotherapy.

Astragalus Shiitake—A Novel Functional Food with High Polysaccharide Content and Anti-Proliferative Activity in a Colorectal Carcinoma Cell Line

mycolabadmin

Scientists developed a new type of Shiitake mushroom by growing it on a special substrate enriched with Astragalus root. This novel mushroom contains significantly more beneficial polysaccharides than regular Shiitake. When tested against colorectal cancer cells, extracts from this mushroom showed strong cancer-fighting properties, with the ultrasound extraction method being most effective. This research suggests Astragalus Shiitake could become a powerful functional food for cancer prevention and treatment.

Antrodia Camphorata Supplement in the Early Life Inhibits Intestinal Tumorigenesis Later in Young Adult APC1638N Mice

mycolabadmin

Researchers found that a mushroom supplement called Antrodia camphorate, when given to mice during childhood and adolescence, helped prevent intestinal tumors when the mice reached young adulthood. This effect was especially strong in mice that ate a high-fat diet early in life. The supplement appears to work by reducing inflammation and blocking certain proteins involved in tumor growth.

Research Topic: colorectal cancer

From Structure to Function: How Prebiotic Diversity Shapes Gut Integrity and Immune Balance

Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways

Lentinan inhibits colorectal cancer stemness by binding CD133 and suppressing the CD133/p85/p-AKT signaling axis

Astragalus Shiitake—A Novel Functional Food with High Polysaccharide Content and Anti-Proliferative Activity in a Colorectal Carcinoma Cell Line

Antrodia Camphorata Supplement in the Early Life Inhibits Intestinal Tumorigenesis Later in Young Adult APC1638N Mice